Author: okorie

Giving a sedating medicine does not, by itself, establish the clinician’s treatment intent.

What the supplied research shows

A qualitative interview study of German healthcare professionals explored intentions when giving sedative drugs in general palliative care. Participants differed in how they understood the term sedation. Themes included relieving the patient’s suffering, responding to distress experienced by teams or families, and distinguishing an intended action from an anticipated effect on consciousness or survival. Some professionals described reduced consciousness as a side effect rather than the treatment goal.

What it cannot establish

Interviews report how selected clinicians described their thinking. They do not determine what happened in a particular death, measure drug concentrations, or establish that an expressed intention matched practice. The findings also reflect a specific care context and terminology.

Forensic interpretation and case review

For a forensic reconstruction involving midazolam or another sedative, identify the recorded symptom, planned depth of sedation, consent discussions, titration and observations after dosing. Intent, physiological mechanism and cause of death are separate questions. Neither a sedative prescription nor a clinician’s choice of words resolves all three. The paper supports careful interpretation of clinical language while leaving factual conclusions dependent on contemporaneous documentation and the patient’s actual course.

Source and related reading

Source: supplied full-text paper, PMC8439055. Research findings are paraphrased; the case-review discussion is an interpretation of that evidence.

Related: A Palliative-Care Cohort Did Not Detect a Benzodiazepine–Delirium Association.

A patient’s experience of sleeplessness and objectively recorded sleep can differ.

What the supplied research shows

A case report described a sixty-year-old woman who had tried multiple hypnotics over approximately ten years. Sleep evaluations documented substantially more sleep than she believed she obtained. The authors diagnosed paradoxical insomnia. Education about the sleep recordings and cognitive behavioral treatment were followed by improved sleep perception, while zolpidem was tapered.

What it cannot establish

This is one case involving several interventions and psychiatric comorbidity. It does not establish the prevalence of sleep misperception among benzodiazepine users or prove that a particular hypnotic caused the complaint. A discrepancy also does not establish deliberate exaggeration or dishonesty.

Forensic interpretation and case review

When evaluating a medication-related sleep claim, separate perceived sleep, recorded sleep, daytime sleepiness and functional performance. They are related but distinct endpoints. Preserve the timing and conditions of sleep testing and the patient’s medication regimen at the time. Failure to report benefit from a sedative does not by itself establish absent absorption or unusual metabolic clearance. The case supports examining the clinical phenotype before drawing a drug-mechanism conclusion; it does not support dismissing a patient’s symptoms simply because a recording shows some sleep.

Source and related reading

Source: supplied full-text paper, PMC8344385. Research findings are paraphrased; the case-review discussion is an interpretation of that evidence.

Related: A Hospital Fall Series Without Nonfalling Controls Cannot Rank the Risk of Individual Sleeping Pills.

The relevant comparison depended on whether patients were concurrently receiving opioids.

What the supplied research shows

A retrospective Medicare cohort included 400,924 adults aged sixty-five or older starting benzodiazepine hypnotics, Z-drugs or low-dose trazodone. Without concurrent opioids, adjusted mortality comparisons did not clearly differ from trazodone. During concurrent opioid use, benzodiazepine hypnotics were associated with higher out-of-hospital and total mortality, with adjusted hazard ratios of 3.02 and 2.21 respectively. The association persisted when overdose deaths were excluded.

What it cannot establish

This was not random assignment, and residual differences between treatment groups could remain. The selected cohort excluded severe illness and evidence of substance use disorder. The absence of a significant difference without opioids does not establish that the drugs were harmless or interchangeable for every outcome.

Forensic interpretation and case review

For a death investigation, identify the actual overlap in use rather than list prescriptions without dates. Mortality associations do not establish a fatal concentration, a precise interaction magnitude in one person, or the cause of an individual death. Consider respiratory disease, cardiac disease, competing causes and the reliability of administration records. The study demonstrates why co-exposure belongs in the analysis while leaving individual causation dependent on the full clinical and toxicological record.

Source and related reading

Source: supplied full-text paper, PMC8321368. Research findings are paraphrased; the case-review discussion is an interpretation of that evidence.

Related: Benzodiazepine Associations in an Overdose Survey Depended on the Time Window Studied.

A dominant-drug classification does not mean that a patient received only that drug.

What the supplied research shows

A retrospective study of 2,837 mechanically ventilated adults in four Canadian ICUs classified the dominant sedation strategy by infusion duration before the first delirium assessment. In propensity-matched comparisons, midazolam-dominant sedation was associated with higher odds of delirium than propofol-dominant sedation, with an odds ratio of 1.46 and a 95% confidence interval of 1.06 to 2.00. Ventilation duration was also longer in the midazolam comparison.

What it cannot establish

Matching balances recorded characteristics, not every reason a clinician selected a sedative. Patients could receive overlapping strategies. The study was observational and hypothesis-generating; it cannot establish that substituting a drug would have prevented delirium in one patient.

Forensic interpretation and case review

An expert should examine the complete infusion record rather than translate the study label into exclusive exposure. Establish whether delirium assessment occurred during comparable levels of arousal and whether illness severity, infection, withdrawal or other medicines offered alternative explanations. The association is relevant background for discussing sedation strategy, but a case opinion requires a defensible timeline and a distinction between confounding by clinical need and a direct medication effect.

Source and related reading

Source: supplied full-text paper, PMC8292822. Research findings are paraphrased; the case-review discussion is an interpretation of that evidence.

Related: Benzodiazepine Use Was One of Several Delirium Predictors After Aortic Repair.

Interview findings can explain why medication changes are difficult without measuring their clinical benefit.

What the supplied research shows

Researchers interviewed eight patients with cirrhosis and fourteen clinicians about medicines associated with hepatic encephalopathy, including benzodiazepines. Patients described concern about symptoms returning and wanted clearer education. Clinicians identified uncertainty about safe deprescribing, limited time and responsibility being deferred among providers. Participants supported additional help from pharmacists or nurses.

What it cannot establish

This was a qualitative study of twenty-two people, not a randomized withdrawal trial. It did not estimate the reduction in encephalopathy produced by stopping a particular medicine, establish a universal taper, or compare every alternative. Views from selected participants may not represent other care settings.

Forensic interpretation and case review

For a case involving liver disease and altered consciousness, separate the medicine’s plausible contribution from the actual clinical course. Review liver status, previous encephalopathy, treatment indication, dose changes and communication between prescribers. The interviews may support questions about coordination and informed discussion, but they cannot establish that immediate cessation would have prevented an event. A report should also avoid treating a patient’s concern about symptom recurrence as evidence of misuse. The study concerns decision-making barriers, not a determination of fault in an individual case.

Source and related reading

Source: supplied full-text paper, PMC8259255. Research findings are paraphrased; the case-review discussion is an interpretation of that evidence.

Related: A Palliative-Care Cohort Did Not Detect a Benzodiazepine–Delirium Association.

A negative metabolic interaction result answers a narrower question than a complete safety assessment.

What the supplied research shows

Phase 1 open-label studies used midazolam as a probe for CYP3A activity while evaluating lemborexant. Midazolam exposure was not meaningfully changed by lemborexant. In the same research program, medicines that inhibited or induced CYP3A substantially changed lemborexant exposure. The direction of the interaction therefore mattered: one medicine being a substrate did not establish that it altered another substrate’s clearance.

What it cannot establish

The midazolam comparison concerned pharmacokinetics under a particular regimen. It did not establish that combining two sedating medicines leaves attention, breathing, balance or driving unchanged. Results from healthy volunteers also do not cover every illness or interacting medicine.

Forensic interpretation and case review

A forensic report should name the measured endpoint: plasma exposure, rather than global clinical safety. Separate an interaction that changes concentration from one that changes the response at similar concentrations. For an individual event, reconstruct administration times, other depressants, organ function and observed behavior. The supplied study supports a limited statement about the tested metabolic pathway; it cannot supply an individualized impairment threshold or a guarantee that concurrent sedative effects were absent.

Source and related reading

Source: supplied full-text paper, PMC8248323. Research findings are paraphrased; the case-review discussion is an interpretation of that evidence.

Related: Oral and Intravenous Midazolam Probes Answered Different Questions in a Napabucasin Study.

Expecting to drink alcohol can change some ratings of hypothetical monetary gains and losses. In a randomized, three-group experiment involving 75 university students, both wine and an alcohol-cued placebo changed selected valuation ratings compared with an openly nonalcoholic drink. The study did not demonstrate that alcohol increased every measure of risk perception, and it cannot establish an impairment threshold at a measured blood alcohol concentration of 0.02%: the participants’ blood and breath alcohol concentrations were not measured during the main experiment.

The useful forensic question is therefore how expectations and study design affect the interpretation of a behavioral result. A calculated alcohol target, a rating on paper and an observed driving deficit represent different kinds of evidence.

What did the 75 participants receive?

Tsurugizawa and colleagues randomly assigned healthy, right-handed, nonsmoking university students to three separate groups. The wine group contained 23 participants: 14 men and nine women. The placebo group contained 23: 15 men and eight women. The control group contained 29: 18 men and 11 women. Participants reported drinking less than once per week. This was a comparison between groups, rather than a crossover in which every person received all three beverages.

The alcohol group drank red wine containing 14% alcohol. Individual beverage volumes were calculated from body weight and sex using a Widmark formula, aiming at an estimated BAC of 0.02 g/100 mL, equivalent to 0.02 g/dL. The paper reports a mean beverage volume of 89.3 ± 3.7 mL. That volume is not a dose in grams of ethanol and must not be relabeled as one.

The placebo and control drinks were alcohol-free, wine-flavored grape juice. An opened, labeled wine bottle supplied an alcohol cue for the wine and placebo groups, whose participants were not told the actual beverage identity. The control participants were told that their drink contained no alcohol. The authors report that the cued groups believed their beverage was wine.

Why was 0.02% a target rather than a measured result?

Breath testing was conducted in a preliminary study, but not in the main volunteers. The investigators wanted to avoid revealing the placebo condition through a breath-test result. They acknowledge that this decision leaves uncertainty about whether the intended alcohol concentration was actually achieved.

No participant-level whole-blood, serum, plasma, urine or breath ethanol series was provided for the main experiment. Consequently, the paper cannot connect a particular measured concentration to a particular participant’s response. Nor can it distinguish individual absorption and elimination profiles. A statement such as “the experiment proved impairment at 0.02% BAC” would turn a dosing assumption into an analytical measurement.

What was tested about 45 minutes after drinking?

Participants were instructed not to eat during the hour before the experiment. They consumed the beverage over approximately ten minutes before an MRI session lasting around 45 minutes, then completed paper-and-pencil tasks within about ten minutes. The published analysis addressed those behavioral tasks independently of the MRI experiments; its results are not reported brain-imaging findings.

For hypothetical gains and losses of 100,000 yen, participants rated subjective likelihood and waiting time at seven stated probabilities, from 0.05 to 0.95. They marked a 180-mm scale. A separate valuation task asked about happiness from gains and aversion to losses for ten hypothetical amounts ranging from 10,000 to 100,000 yen. These were ratings of imagined outcomes, not actual monetary losses, risky driving or observed harmful conduct.

Which findings were significant, and which were not?

Compared with the informed control, the wine group showed lower subjective valuation ratings for amounts from 10,000 through 50,000 yen. The alcohol-cued placebo also produced lower ratings for the two smallest amounts, 10,000 and 20,000 yen. Thus, a beverage-associated change in selected ratings did not require the active wine condition.

For the likelihood and waiting-time measures, the reported tables showed no significant beverage main effects at the tested probabilities. There were differences associated with gain versus loss and, for some likelihood comparisons, sex. Those differences should not be described as evidence that alcohol made women or men more impaired.

The investigators also fitted Stevens’ power functions to the ratings. Nonlinear models fitted the task data better than linear models. For the valuation exponent, placebo differed significantly from control, while wine did not show that significant contrast. This pattern does not, by itself, prove that placebo had a larger effect than wine. A significant result in one comparison and a nonsignificant result in another is not a direct statistical test of the difference between those effects.

What limits the interpretation?

The six sex-by-beverage subgroups were small and unequal, with eight to 18 participants each. The young, infrequently drinking university sample does not represent all drivers, patients or habitual drinkers. The study examined several outcomes, probabilities, monetary amounts and model parameters; its selective findings need to retain their particular endpoints rather than becoming a single claim about overall judgment.

The authors also acknowledge that using the same 180-mm scale does not establish that gain happiness and loss aversion are psychologically equivalent quantities. Hypothetical money may not elicit the same response as real consequences. The uncertain achieved ethanol concentrations further restrict any dose-response inference.

How should the study inform an expert opinion?

The experiment supports considering expectancy when interpreting subjective monetary valuation after a purported alcoholic drink. It does not establish a safe alcohol concentration, diagnose an individual’s impairment, quantify crash risk, determine legal capacity or explain why a disputed act occurred. Those conclusions would require evidence connecting the relevant person, timing, exposure and functional task.

Related research on this site examines alcohol-cued placebo effects on lightheadedness and motivation. That is a different endpoint from monetary valuation. Neither type of subjective response substitutes for a measured ethanol concentration or a validated assessment of the function at issue.

Primary study

Tsurugizawa T, Tokuda S, Harada T, Takahashi T, Sadato N. Pharmacological and Expectancy Effects of a Low Amount of Alcohol Drinking on Outcome Valuation and Risk Perception in Males and Females. PLoS ONE. 2016;11(4):e0154083. doi:10.1371/journal.pone.0154083.

A more demanding task did not produce a larger detectable alcohol effect in a 20-man inhibition experiment. Alcohol increased errors in easier conditions, while the sober-versus-intoxicated difference was not significant in the hardest condition. This does not mean difficult work reverses intoxication. It shows why the structure of a test can change what an alcohol comparison detects.

Stock and colleagues’ 2022 study combined behavioral analysis with EEG measures of theta and alpha activity. The findings concern working-memory demands and preparation for upcoming trials, rather than a general clinical test of sobriety.

One sample, with earlier behavioral data

The participants were 20 healthy, right-handed men aged 19–32. This was not an independent replication of the authors’ earlier behavioral experiment: the sample largely overlapped that work, with two additional participants included because their earlier exclusion concerned Go-response accuracy, which was not the present analysis’s focus.

Researchers tested sober performance before the alcohol appointment. Appointment order was fixed, as was the order of the two task blocks. These choices limit separation of alcohol effects from order-related influences, even though supplementary analyses did not indicate a straightforward learning explanation.

The oral vodka dose was calculated using estimated total body water and an assumed 20% absorption deficit to target approximately 1.2 per mille in blood-equivalent terms. Participants received a mean 92.0 g of ethanol, mixed with orange juice, consumed it within 30 minutes and waited another 30 minutes. This was a calculated target, not an administered dose of 1.2 grams per liter.

Alcohol exposure was checked with a Dräger breath instrument immediately before and after testing. The paper labels the means as BrAC of 1.01 and 1.08 per mille, also expressing them as 101 and 108 mg/dL. Those are the paper’s blood-style reporting conventions for breath-derived values; they are not independently assayed whole-blood concentrations. Serum, plasma and urine ethanol were not measured to establish a pharmacokinetic curve.

How workload changed the response rule

The combined Go/No-go and mental-rotation task presented letters and numbers at different angles, sometimes mirrored. Participants pressed a button on Go trials and withheld responses on No-go trials. Go trials outnumbered No-go trials seven to three, encouraging a prepotent response.

The more demanding first block required distinguishing mirrored from non-mirrored stimuli. The second block used letter-versus-number rules. Rotation angles added another demand, although the primary analysis excluded 90-degree trials. The full paradigm lasted about 30 minutes.

A false alarm meant responding when the rule required withholding the response. That is a defined laboratory error, rather than an observation of a person losing control in everyday life.

The positive and null findings must travel together

Across the easier second block, false alarms averaged 2.09% during intoxication versus 0.14% sober. The alcohol effect was significant, p = 0.014, and a nonparametric comparison also supported the difference.

In the first block’s 30-degree condition, errors averaged 14.72% intoxicated versus 8.89% sober, with a significant paired nonparametric comparison, p = 0.006. But at 150 degrees in that more demanding block, the sober-versus-intoxicated comparison was not significant, p = 0.413.

The difficult block had more false alarms overall than the easy block. Therefore, the smaller detectable alcohol difference in the hardest condition cannot be translated into better absolute performance, equivalence to sobriety or safe driving. Absolute task difficulty and the difference attributable to an experimental condition are different quantities.

What the EEG timing adds

The strongest workload-related differences in alcohol effects appeared approximately 750–1,500 milliseconds after stimulus presentation, later than the interval usually associated with the immediate motor-inhibition operation. The researchers compared the easiest and hardest No-go conditions and used source estimation to investigate associated brain regions.

The pattern was consistent with altered working-memory engagement or anticipatory attentional processing between trials. One interpretation is that easy, repetitive rules permit a stronger automatic Go tendency, placing greater demands on inhibition. Harder response selection can slow or weaken that automatic tendency.

These remain mechanistic interpretations. Source estimation does not directly measure individual neurons, and the analysis contrasted how alcohol effects differed between task conditions. It did not identify a universal EEG signature of impairment or prove that one particular mechanism caused each error.

What an expert can reasonably infer

The study supports examining the actual response rule, workload, error definition and testing time before treating a normal score as evidence of normal function. It also cautions against assuming that every harder test must reveal a larger alcohol effect.

The sample was small and exclusively male; no placebo condition separated expectancy from exposure, order was fixed, and the EEG analysis focused on selected conditions. No real-road driving, crash causation or person-level diagnostic cutoff was validated. Making a task harder is not an established intervention for restoring safe performance after alcohol.

For a different inhibition question, see our analysis of visual stop-cue processing and response stopping. That experiment examined another task and neural method; its results do not supply the missing individual validation here.

Primary scientific source

Stock AK, Yu S, Ghin F, Beste C. How low working memory demands and reduced anticipatory attentional gating contribute to impaired inhibition during acute alcohol intoxication. Scientific Reports. 2022;12:2892. doi:10.1038/s41598-022-06517-9.

Alcohol increased hostile interpretations of ambiguous facial expressions in one controlled experiment, but it did not significantly increase hostility ratings overall or demonstrate that anyone became violent. The distinction matters when scientific evidence is used to explain a disputed confrontation. Recognizing an emotion, interpreting hostility and acting aggressively are separate outcomes.

Eastwood and colleagues’ 2026 study examined judgments about briefly displayed faces and responses on a joystick task. It offers evidence about a possible perceptual pathway, rather than a test of whether alcohol caused an individual assault.

What the experiment administered and measured

Eighty-four social drinkers, half male, completed alcohol and placebo sessions at least seven days apart in a counterbalanced, double-blind design. Participants were aged 18–40, with a mean age of 22.5 years. The alcohol drink contained vodka and tonic, with a nominal ethanol dose of 0.4 g/kg. Dosing was capped at the amount calculated for 90 kg, so participants above that weight did not receive the full nominal weight-adjusted dose.

Participants drank within ten minutes, waited another ten minutes and then completed the hostility and approach/avoidance tasks in a fixed order. Together the tasks lasted approximately 30 minutes. The protocol intended to capture rising or near-peak exposure, but it did not continuously measure the alcohol curve throughout each task.

Post-session breath alcohol ranged from 8 to 32 micrograms per 100 mL of breath, with a mean of 16.62 and standard deviation of 4.81. These are breath concentrations, not grams per deciliter of whole blood. No paired venous whole-blood, serum or plasma series established an individual blood concentration or elimination rate.

The overall result was null; ambiguity changed the pattern

Participants classified briefly presented composite male faces as hostile or not hostile. Facial intensity ranged from ambiguous to clear emotional expression. Surprise-expression data were excluded because of a programming error, leaving angry, happy, sad, disgusted and fearful expressions in the analysis.

The primary overall alcohol effect was not statistically significant: p = 0.342. Descriptive global hostility ratings averaged 31.61% after alcohol and 30.51% after placebo. An account that simply says alcohol made all faces seem more hostile would misstate that result.

The exploratory drink-by-intensity interaction was significant, p = 0.002. Alcohol was associated with more hostile interpretations at the ambiguous end of the continuum, with the difference diminishing as expression became clearer. The model reported an approximately 3.48-percentage-point increase at its lowest-intensity reference. That estimate is a task-specific model result, not the probability that a witness misread a real person’s intentions.

For happy expressions, descriptive hostility ratings averaged 8.09% after alcohol versus 5.07% after placebo; the modeled drink effect was significant, p = 0.009. There were no significant drink main effects for the other four expressions. An additional exploratory interaction for angry expressions indicated greater hostility judgments at low intensity, rather than a uniform increase across all angry faces.

Faster joystick responses did not establish greater approach toward threat

The second task asked participants to push or pull a joystick according to the image border, rather than explicitly judging its emotional meaning. Three participants were excluded from this analysis for unusually high error rates.

Alcohol shortened response times across emotions by approximately 21–26 milliseconds. But the alcohol-by-approach/avoidance interactions were not significant for any emotion, all p values above 0.260. Faster responding in both directions is different from preferentially approaching a hostile face. State-anger ratings also did not show significant alcohol-related changes.

The task’s negative split-half reliability coefficient, r = −0.32, further limits interpretation of the approach/avoidance null result. It neither proves that motivation was unaffected in every person nor supports an increased tendency to attack.

Why this cannot reconstruct a confrontation

The laboratory presented isolated faces for 150 milliseconds, without the speech, relationship history, movement and setting of a real encounter. Participants were selected social drinkers, rather than a representative forensic population. Most identified the alcohol session, limiting the success of blinding: 83.3% believed they had alcohol in that condition versus 40.5% in the placebo condition. Pharmacological effects and expectations were therefore not cleanly separated.

The study was powered for an overall alcohol effect; interaction and subgroup findings require particular caution. The analysis also changed from the originally planned approach, and multiple emotions and intensities were examined. These qualifications belong alongside the positive findings.

A defensible use of the study identifies a possible change in interpreting ambiguous social cues while retaining the null global result and absence of observed violence. It does not establish what someone saw, whether a threat existed, intent, credibility or causation in a particular case. Our separate analysis of anger recognition and reported empathy addresses different social-cognition measures; those outcomes should not be substituted for hostility attribution.

Primary scientific source

Eastwood APR, Penton-Voak IS, Munafò MR, Attwood AS. Effects of acute alcohol consumption on hostile attribution bias towards emotional facial expressions and implicit approach/avoidance tendencies. Journal of Psychopharmacology. 2026;40(9):1392–1404. doi:10.1177/02698811251408743.

Hangover severity cannot be used as a validated estimate of an individual’s alcohol elimination rate. A small exploratory analysis found an association between faster breath-alcohol disappearance and less severe hangover, but it combined two separate experiments involving only eight people. The laboratory alcohol challenge and the night that produced the hangover occurred about a year apart.

The 2020 study by Mackus and colleagues offers a hypothesis about alcohol metabolism and next-day symptoms. It does not supply an equation for calculating an earlier blood alcohol concentration from how sick someone feels.

Two studies supplied different pieces of the comparison

Five men and three women participated in both studies. They were young, healthy social drinkers; mean age was 20.4 years during the 2015 hangover study and 21.4 years during the 2016 laboratory challenge.

In the laboratory, participants ate a standardized meal and received an individually calculated oral ethanol dose mixed with orange juice to make a 250 mL beverage, consumed within five to ten minutes. The mean ethanol amount was 33.7 mL, with a standard deviation of 8.9 mL. This is ethanol volume, not grams per kilogram. Dosing targeted a reported breath alcohol concentration of 0.05%.

Breath measurements were taken every five minutes until two consecutive readings were zero. The investigators calculated an average disappearance rate by dividing peak breath concentration by elapsed time from peak until zero. The mean was 0.016 in the paper’s reported BrAC percentage units per hour, with a range of 0.012–0.019. This was not serial laboratory measurement of whole-blood ethanol, and the calculated average is not a direct assay of an enzyme’s activity.

The other study followed a normal night out. Researchers did not control beverage selection, drinking duration, activity or alcohol amount. Participants retrospectively reported a mean 11.8 drinks, with a standard deviation of 5.8. An adjusted Widmark calculation produced a mean estimated BAC of 0.20%, standard deviation 0.10%. Those were model estimates from reported drinking, not measured peaks from that evening.

The statistical signal depended on the analysis

Participants rated overall hangover from zero to ten at seven hourly assessments, from 10 a.m. through 4 p.m. Partial correlations between elimination rate and severity, controlling for estimated BAC, were negative at every timepoint. Faster laboratory disappearance therefore tended to accompany lower reported symptoms in this small dataset.

The original-sample p values in Table 2 ranged from 0.130 to 0.467; none was below 0.05. After 10,000 bootstrap resamples, bias-corrected confidence intervals excluded zero at 11 a.m., 1 p.m. and 2 p.m. They included zero at the other four assessments. The abstract and table identify those three times; the Results prose contains an inconsistent clock-time label, which should not be treated as an additional finding.

At 1 p.m., for example, the original partial correlation was −0.508, with p = 0.244. The reported bootstrap correlation was −0.472 with a 95% interval of −0.922 to −0.221. Reporting only “significant correlation” would conceal both the small sample and the dependence of significance on the resampling approach.

Bootstrap resampling repeatedly draws from the same eight participants. It can explore uncertainty under the selected method, but it does not turn eight people into 10,000 independent observations. Seven related timepoint comparisons also warrant caution when interpreting a selected subset of positive findings.

The year between studies matters

The analysis assumes that disappearance measured after the lower laboratory exposure meaningfully ranks participants’ elimination during a much heavier drinking occasion. That transfer was not directly measured. The authors discussed the possibility of different elimination kinetics at higher exposures and called for replication measuring both processes in one study.

Most recorded demographic characteristics did not differ significantly across the two studies, but that does not establish identical physiology, food intake, sleep, exposure or circumstances. A year-separated association is weaker evidence for an event-specific mechanism than simultaneous measurements would be.

Symptoms, elimination and impairment remain separate questions

The analysis did not test driving, establish a diagnostic cutoff for hangover, or validate an individual impairment classifier. It cannot establish that a person without symptoms eliminated alcohol unusually quickly, that severe symptoms imply residual ethanol, or that either person was safe to drive.

It also did not randomize a treatment intended to accelerate metabolism. An association between elimination and symptoms cannot by itself prove that a supplement or other intervention prevents hangover. The source reports several authors’ commercial research or consulting relationships; the study itself reported no external funding.

The useful forensic lesson is to preserve the chain of measurements: a breath-derived disappearance estimate from one occasion, retrospective drinking estimates from another, and subjective symptom scores the next day. None substitutes for a specimen collected at the disputed event. For a separate functional question, see our analysis of hangover and combined multitasking performance.

Primary scientific source

Mackus M, van de Loo AJAE, Garssen J, Kraneveld AD, Scholey A, Verster JC. The Association between Ethanol Elimination Rate and Hangover Severity. International Journal of Environmental Research and Public Health. 2020;17:4324. doi:10.3390/ijerph17124324.